Macrolide-resistant Streptococcus pneumoniae clinical isolates that occur in Hokkaido prefecture, Japan

Journal of Infection and Chemotherapy

Volumn 10, Issue 5, 2004, Pages 284-287

  Yokota, Shin Ichi ^a   Sato, Kiyoshi ^a,b   Yoshida, Shigeru ^c   Hayashi, Tasuku ^d   Matsuda, Keiko ^d   Kuwahara, Osamu ^e   Habadera, Satoshi ^e   Kobayashi, Kazuhiko ^f   Ueno, Ryo ^f   Akizawa, Hirotsugu ^c   Fujii, Nobuhiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hokkaido Wako Junyaku Co Ltd   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^d Muroran General Hospital   (Japan)

^e Sapporo Clinical Laboratory Inc   (Japan)

^f Daiichi Clinical Laboratories Inc   (Japan)

Author keywords

Drug resistance; erm(B); Macrolide; mef(A); Streptococcus pneumoniae

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; ROKITAMYCIN;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; HOSPITAL; LABORATORY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

EID: 19944429891     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0340-4     Document Type: Article

References (17)

1. Adam D. Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002;50:1-5.
2. Appelbaum PC. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infect Dis 2002;34:1613-20.
3. Inoue M, Lee NY, Hong SW, Lee K, Felmingham D. PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int J Antimicrob Agents 2004;23:44-51.
4. Nuermberger E, Bishai WR. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Clin Infect Dis 2004;38:99-103.
5. Song J-E, Chang H-H, Suh JY, Ko KS, Jung S-I, Oh WS, et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian network for surveillance of resistant pathogens (ANSORP). J Antimicrob Chemother 2004;53:457-63.
6. Ubukata K. Problems associated with high prevalence of multidrug-resistant bacteria in patients with acquired infections. J Infect Chemother 2003;9:285-91.
7. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995;39:577-85.
8. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolide but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996;40:1817-24.
9. Leclercq R, Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother 2002;46:2727-34.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. M100-S8. vol. 18. Villanova, PA: NCCLS; 1998.
11. Ubukata K, Muraki T, Igarashi A, Asahi Y, Konno M. Identification of penicillin and other beta-lactam resistance in Streptococcus pneumoniae by polymerase chain reaction. J Infect Chemother 1997;3:190-7.
12. Ubukata K, Iwata S, Sunakawa K. In vitro activities of a new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. J Infect Chemother 2003;9:221-6.
13. Ubukata K, Kobayashi R, Chiba N, Hasegawa K, Konno M. Surveillance based on molecular epidemiology for Streptococcus pneumoniae isolates between 1998 and 2000 in Japan. Results of clinical isolates collected by the Community-Acquired Bacterial Infections Working Group (in Japanese). Jpn J Chemother 2003;51:60-70.
14. Lynch JP III, Martinez FJ. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin Infect Dis 2002;34:S27-S46.
15. Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 2001;286:1857-62.
16. Yokota S, Sato K, Kuwahara O, Habadera S, Tsukamoto N, Ohuchi H, et al. Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan. Antimicrob Agents Chemother 2002;46:3311-5.
17. Yokota S, Sato K, Yoshida S, Fujii N. Molecular epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae in Japan (in Japanese). Kansenshogaku Zasshi 2004;78:428-34.